Shanghai Pharma Plans To Acquire New Asiatic, Shanghai Asia Pioneer
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceutical recently announced its plan to acquire 96.9 and 100 percent stakes in New Asiatic Pharmaceutical and Shanghai Asia Pioneer Pharmaceutical for RMB 1.488 billion, which will enable Shanghai Pharmaceutical to list its entire antibiotics business